Deferred Tax Assets, Gross of LakeShore Biopharma Co., Ltd. from 31 Mar 2023 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
LakeShore Biopharma Co., Ltd. quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Mar 2023 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Deferred Tax Assets, Gross for the quarter ending 31 Mar 2025 was $3,992,275, a 6% increase year-over-year.
LakeShore Biopharma Co., Ltd. quarterly Deferred Tax Assets, Gross in CNY history and change rate from 31 Mar 2023 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Deferred Tax Assets, Gross for the quarter ending 31 Mar 2025 was ¥28,657,342, a 7.3% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)
Deferred Tax Assets, Gross, Quarterly (CNY)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

LakeShore Biopharma Co., Ltd. Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,992,275 +$226,538 +6% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 $3,765,737 31 Mar 2024 20-F 15 Aug 2024 2024 FY

LakeShore Biopharma Co., Ltd. Quarterly Deferred Tax Assets, Gross (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 ¥28,657,342 +¥1,939,439 +7.3% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 ¥26,717,903 +¥20,935,358 +362% 31 Mar 2024 20-F 31 Jul 2025 2025 FY
Q1 2023 ¥5,782,545 31 Mar 2023 20-F 15 Aug 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.